ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OKYO Okyo Pharma Limited

91.00
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Okyo Pharma Limited LSE:OKYO London Ordinary Share GG00BD3FV870 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 91.00 1.20 1.60 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Okyo Pharma Share Discussion Threads

Showing 651 to 671 of 725 messages
Chat Pages: 29  28  27  26  25  24  23  22  21  20  19  18  Older
DateSubjectAuthorDiscuss
19/3/2023
11:00
20220516 RNS explains conversion principle and NASDAQ listing.A good place to start.
bibs
18/3/2023
17:18
Hi why is just a big price difference between Nasdaq and LSE share price 2.75 v/s 1.55?
spkp313703
17/3/2023
07:49
OKYO on NASDAQ opened over 90 percent up on placement price, on appreciation of trial news yesterday.


Closed 14 percent up on very high volume.


Great prospects ahead ?

bibs
16/3/2023
15:46
Huge volume being traded over on NASDAQ - they understand and like the RNS(s).
faraweigh2
16/3/2023
11:22
OKYO Pharma Announces Phase 2 Trial of OK-101 Drug to Treat Dry Eye Disease is now listed on the ClinicalTrials.gov Public Website.



"We are excited to be very close now to moving this drug into its first clinical trial and believe that OK-101 can provide a new way to treat DED patients who are presently not well-served by currently approved drugs" said Gary S. Jacob, Ph.D., CEO of OKYO Pharma Ltd.

bibs
16/3/2023
10:56
Market Capitalisation is a small fraction of where it will be in time.Funding sorted and set for real growth in due course.DYOR
faraweigh2
16/3/2023
08:16
Funding in place and trials underway. Good to go!
faraweigh2
16/3/2023
07:28
1.9p placing huh. Whoosh.
terminator101
15/3/2023
10:39
Life changing positive potential here for those with sufficient skin in the game.Sit back and watch it unfold ; )
faraweigh2
14/3/2023
15:51
Bibs did you take any profit off the table at 8p to BUY at under 3p or were you greedy too?. :0)
p5tvr
14/3/2023
15:26
Won't Buy these at under 2.5p for much longer:

" offerings utilized the full amount of the Company’s UK ordinary shares available for sale at this time "

bibs
14/3/2023
14:55
Reread the thread bell end.Some understand what's happening here and some don't have a clue.You sit amongst the latter lol!
faraweigh2
14/3/2023
12:21
Management and investors well placed now for future gains.Funding in place for significant growth.
faraweigh2
14/3/2023
12:02
Yes . 2023 is going to be a big year for them . like every year since they assembled this pile of excrement.
kasspass
14/3/2023
11:12
lol absolutely clueless ; )
faraweigh2
14/3/2023
08:59
Oh dear!! Hands up those who wished that they now sold into the spike to 8p? That's what you get for being too GREEDY. LOL :0)
p5tvr
13/3/2023
15:49
Okyo CEO states:"2023 is going to be a big year for us!"Shareholder value to be added here...
bibs
04/3/2023
12:10
Hearing IIs accumulating here ahead of significant, global exposure to DE treatment markets.Trade patterns and volumes appear to back this up.DYOR
faraweigh2
02/3/2023
11:15
Next rinse and repeat at 0.911p.

You have been warned.

Regards,
F911
RMC

firestorm911
01/3/2023
13:17
Oops! LOL. :0)
p5tvr
28/2/2023
15:23
So much for that rise to 8p! LOL :0)
p5tvr
Chat Pages: 29  28  27  26  25  24  23  22  21  20  19  18  Older

Your Recent History

Delayed Upgrade Clock